Mesenchymal Precursor Cells for Heart Failure (IMAGE)

Texas Heart Institute

Mesenchymal Precursor Cells for Heart Failure

Caption

The DREAM-HF findings of long-term improvements in outcomes for patients with heart failure are an important milestone in the field of cardiac cell therapy. The results will be used to design definitive clinical trials for examining cell therapy in patients with heart disease and may help in identifying those most likely to benefit from MPC therapy. This seminal trial sets the stage for eventually adding cell therapy to the treatment arsenal for heart failure.

Credit

© Copyright Texas Heart Institute

Usage Restrictions

© Copyright Texas Heart Institute

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.